Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Oral minoxidil is a safe and effective treatment for patterned hair loss.

Low-dose oral minoxidil is effective and well-tolerated for treating hair loss.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.